The Lancet. Infectious diseases
Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open
Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae - Authors' reply.
Intention-to-diagnose and distinct research foci in diagnostic accuracy studies.
Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension.
Threat of HIV and tuberculosis drug resistance after US funding cuts.
Targeting the SARS-CoV-2 reservoir in long COVID.
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.
Plasma-based antigen persistence in the post-acute phase of COVID-19.
The emergence of artemisinin partial resistance in Africa: how do we respond?
Post-viral sequelae of COVID-19 and influenza.
